financetom
Business
financetom
/
Business
/
OSI Systems Awarded $7 Million Order to Supply Medical Technology Components
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OSI Systems Awarded $7 Million Order to Supply Medical Technology Components
May 26, 2025 5:57 AM

10:30 AM EDT, 05/12/2025 (MT Newswires) -- OSI Systems ( OSIS ) said Monday that it was awarded a $7 million order to supply medical technology components to an unnamed healthcare company that specializes in patient diagnostics and care applications.

Shares of the company were up 1.9% in recent trading.

Price: 227.80, Change: +4.27, Percent Change: +1.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Loar Likely to Benefit From Strong A&D Fundamentals in Q3, RBC Says
Loar Likely to Benefit From Strong A&D Fundamentals in Q3, RBC Says
Nov 12, 2024
12:41 PM EST, 11/12/2024 (MT Newswires) -- Loar Holdings ( LOAR ) is expected to gain in Q3 from strong Aerospace & Defense fundamentals, scarcity value, and a positive M&A landscape, RBC Capital Markets said in a report emailed Tuesday. Loar ( LOAR ) will report its Q3 earnings on Wednesday, RBC said. We expect the company to exceed 3Q24...
Sphere Entertainment Swings to Fiscal Q1 Loss, Revenue Rises
Sphere Entertainment Swings to Fiscal Q1 Loss, Revenue Rises
Nov 12, 2024
08:50 AM EST, 11/12/2024 (MT Newswires) -- Sphere Entertainment ( SPHR ) reported a fiscal Q1 loss Tuesday of $2.95 per share, swinging from earnings of $1.89 per share a year earlier. Analysts expected a loss of $2.76. Revenue for the quarter ended Sept. 30 was $227.9 million, up from $118 million a year earlier. The consensus forecast was $247.5...
Novavax Q3 Loss Narrows, Revenue Falls; 2024 Revenue Guidance Lowered -- Shares Down Pre-Bell
Novavax Q3 Loss Narrows, Revenue Falls; 2024 Revenue Guidance Lowered -- Shares Down Pre-Bell
Nov 12, 2024
08:45 AM EST, 11/12/2024 (MT Newswires) -- Novavax ( NVAX ) reported a Q3 loss Tuesday of $0.76 per diluted share, narrower than the loss of $1.26 a year earlier. Four analysts polled by Capital IQ expected a loss of $0.81. Revenue for the quarter ended Sept. 30 was $84.5 million, down from $187 million a year earlier. Five analysts...
Apogee Therapeutics' Q3 Net Loss Widens
Apogee Therapeutics' Q3 Net Loss Widens
Nov 12, 2024
08:45 AM EST, 11/12/2024 (MT Newswires) -- Apogee Therapeutics ( APGE ) reported a Q3 net loss Tuesday of $49 million, wider than the loss of $20.8 million a year earlier. Analysts polled by Capital IQ expected a loss of $43.9 million. No revenue for the quarter ended Sept. 30 was reported. As of Sept. 30, the company said it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved